… The synthetic compounds, especially those compounds with muscarinic receptor antagonist
and β 2 AR agonist dual activities represent the future direction toward the development of …

… /or β 2 ‐adrenoceptors, more recent preclinical evidence supports a possible role of β 3 ‐…
existing uses as well as several potential future uses require further investigation, hopefully …

… minimal preference for β 2 -AR over β 1 -AR present a complex … randomized prospective
study assessing the effects of a β 2 -… careful consideration and personalised treatment plans. If β-…

… of β agonist use (pharmacogenetics). Finally we comment on what the future may hold for the
use of β agonists in … classes of β agonists available and consider their current clinical use. …

… the adrenergic pathways for alpha 1 and alpha 2 receptors and the current as well as potential
future … Overall, there is ongoing research into a multitude of directions with a promising …

… current knowledge in the field, opening with an outlook on the β adrenergic system and closing
with future directions… Most studies conclude that β2 adrenergic agonists exert a protective …

… One recent study has found that β 2 -agonists regulate the transcription of α-synuclein gene
… [66], which has opened a new path toward identification of biased ligands and development …

… current therapeutic arsenal for reducing IOP includes prostaglandin analogs, β-blockers,
carbonic anhydrase inhibitors, α-adrenergic agonist, … of art on adrenergic modulators for treating …

… β 2 -adrenoreceptor agonists with bronchodilating effects that last for more than 24 hours
(ultra-LABAs), and other more novel molecules are a primary focus of research in recent years …

… More importantly, we present our latest research describing the role played by mast cells in
impairing β2-adrenoceptor … Future clinical trials are needed to determine whether TAS2R …